Provider P8-18 Changes to PA for Hip Arthroplasty, Hip Resurfacing and Knee Arthroplasty for Commercial and Government Programs Lines of Business Read More
Provider P54-17 Clarification to Commercial Prior Authorization Requirements for Early Intensive Behavioral Intervention (EIBI) Read More
Provider P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna) Read More
Provider P51-18 Lab Management Program CPT Code Update for Fully Insured Commercial Members - eviCore Healthcare Specialty Utilization Management (UM) Program Read More
Provider P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis Read More
